ReLive Biotechnologies Limited
Rick Doucette is an accomplished executive in the biotechnology and medical sectors, currently serving as SVP Head of Global Commercial Operations at ReLive Biotechnologies Limited since March 2024. Previously, Rick held the role of Chief Commercial Officer at Cervos Medical, overseeing commercialization efforts and reporting to private investors. Rick's experience includes serving as GM & VP of Sales and Marketing at CarboFix, where significant growth was achieved through strategic relationships and fundraising efforts, resulting in a 900% revenue increase. Additionally, Rick has held positions at Merit Medical Systems, Inc., as US Director of Marketing, and at SPRS as Vice President of Sales, where high growth was accomplished. An MBA in Finance & Marketing from Suffolk University and a BS in Biochemical Engineering from UMass Boston complement Rick's extensive industry expertise.
This person is not in any teams
This person is not in any offices
ReLive Biotechnologies Limited
ReLive is a pioneering global biotechnology company, founded in 2021 by a team of distinguished visionaries and accomplished experts in the fields of tissue engineering, regenerative medicine, and cell therapy. Backed by venture capital, along with the acquisition of CO.DON, ReLive brings together a diverse team of scientists, surgeons, managers and regulatory experts with extensive and direct experience in biotechnology, to collaborate and develop groundbreaking treatments that improve patient outcomes. Through our ongoing research and development efforts, we strive to make a lasting impact on the field of biotechnology and cell therapy and revolutionize the treatment of or theopoetic and reconstructive conditions.